Current filters:  
United States
Holland & Knight
In this episode of "Counsel That Cares," healthcare attorney Daniel Patten is joined by Susan Dentzer, president and CEO of America's Physician Groups (APG), to discuss the benefits and incentives...
Foley & Lardner
Foley & Lardner LLP recently co-hosted a webinar with the National Association of Corporate Directors (NACD) Northern California Chapter's new AI and Technology Cohort...
Ropes & Gray LLP
We are pleased to introduce a new Ropes & Gray podcast series, Recent Trends & Developments in Health Care Joint Ventures. With increased regulatory scrutiny by state and federal regulators of mergers and acquisitions...
Bass, Berry & Sims
With the mergers and acquisitions (M&A) activity no longer at its peak, parties are still utilizing various tools to close the valuation gap.
Bass, Berry & Sims
With choppy debt markets, 2023 has proven to be the "year of the tuck-in" for PE buyers. PE firms largely have looked to shore up their existing physician practice platforms...
McGuireWoods LLP
Blue Heron Capital has closed out its latest fund with $102 million, according to industry reports. The new fund, Blue Heron Capital Fund III, was oversubscribed.
Although most of the recent focus around the implementation of the Inflation Reduction Act ("IRA") by the press and industry stakeholders has been on the Medicare Drug Price Negotiation Program...
As discussed throughout this Update, the implementation of the Medicare Drug Price Negotiation Program (the "Negotiation Program" or "Program")...
Shipman & Goodwin LLP
The national legal battle over abortion access continues as the U.S. Department of Justice and a distributor of abortion medication, mifepristone, urges the U.S. Supreme Court to review a Fifth Circuit...
Bass, Berry & Sims
On September 13, the Alaska Board of Pharmacy (Board) issued a notice summarizing a regulatory update stating that pharmacies, wholesale drug distributors, outsourcing facilities...
Bass, Berry & Sims
As discussed in the initial 2023 Healthcare Private Equity Outlook & Trends publication released in January 2023, sponsors and company management faced a number of notable headwinds as they entered 2023...
Perkins Coie LLP
We are pleased to publish our first midyear Food and CPG Legal Trends report.
The ability to directly negotiate drug prices has been a policy goal for Democrats for many years and was recently accomplished through the Inflation Reduction Act's ("IRA")...
The Inflation Reduction Act ("IRA") was passed just over a year ago with a goal of lowering high drug costs for Medicare beneficiaries and reducing costs incurred by Medicare.
August 16, 2023 marked the one-year anniversary of the enactment of the Inflation Reduction Act ("IRA").
Manatt, Phelps & Phillips LLP
Editor's Note: Manatt on Health—Manatt's premium legal and health policy subscription service covering the topics and trends transforming health care—includes access to a robust series of detailed...
Holland & Knight
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
Crowley Law LLC
Come hear a distinguished leader of the pharmaceutical industry speak about the impact of technology on the biopharmaceutical industry.
Foley Hoag LLP
Interchangeable biosimilar products would not be allowed to disclose or explain their interchangeability designations in their products' labels under FDA's new draft guidance.
Arnold & Porter
In late 2021, a district court1 dismissed an FCA suit filed by the U.S. and Virginia where the governments pursued a surprising theory (at least as to the federal government): that Walgreens made material misrepresentations...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media